Webinar Replay: A “Dope” Response to Pharmacy Transparency

Watch a replay of the third webinar in Humaculture, Inc.’s Hidden Opportunities, Strategic Compliance Series, which focuses on why the new pharmacy transparency law will not increase transparency; will increase costs, administration, and litigation risk; and how to effectively respond.

Presenters

• Steve Cyboran, ASA, MAAA, FCA, CEBS, actuary and strategy consultant
• Wes Rogers, Humaculturist® and strategy consultant
• Jack Towarnicky, LLM, JD, MBA, CEBS, attorney, strategy and compliance consultant
• Scott McKibbin, strategy and pharmacy consultant

Objective

Beyond basic compliance, this series addresses how to strategically leverage the No Surprises Act to create a competitive financial advantage for both the plan sponsor and plan participants. This session focuses on leveraging Acquisition Cost Based Pharmacy Pricing as well as Behavioral Design and Messaging as an example of a strategic action organizations can take to optimize this compliance opportunity.

Pharmacy Transparency Key Takeaways

During this session, participants will learn:

• Transparency is a misnomer – New rules don’t provide transparency
• Pharmacy is likely to continue to be rather “opaque”
• The conundrum – mere compliance will likely increase costs, administration, and litigation risk
• How to use Acquisition Cost Based Pharmacy Pricing as well as Behavioral Design and Messaging as examples of strategic actions to:
  • Avoid what can be avoided
  • Provide true transparency with pharmacy benefits
  • Empower consumers to make better, more clinically appropriate decisions
  • Communicate all negatives as the result of compliance
  • Inform/educate consumers (before they become patients)

Available Support

We are available to support you in your strategy, design, compliance, financial, and monitoring needs. To that end, our team of consultants, including actuaries, clinicians, behavioral health, pharmacy, and legal resources are available to guide you through the compliance process. Please contact us: [email protected].

Watch

Watch the Hidden Opportunities: Preserving the Harvest…Leveraging HSAs Webinar Replay below, or via Rumble.

Hidden Opportunities, A Strategic Compliance Series: A “Dope” Response to Pharmacy Transparency

You can now access a replay of this webinar here.

Join us on Thursday, March 17 from 12:00 to 12:30 CST for the third webinar in Humaculture, Inc.’s Hidden Opportunities, Strategic Compliance Series, to learn why the new pharmacy transparency law will not increase transparency; will increase costs, administration, and litigation risk; and how to effectively respond.

Presenters

• Steve Cyboran, ASA, MAAA, FCA, CEBS, actuary and strategy consultant
• Wes Rogers, Humaculturist® and strategy consultant
• Jack Towarnicky, LLM, JD, MBA, CEBS, attorney, strategy and compliance consultant
• Scott McKibbin, strategy and pharmacy consultant

Objective

Beyond basic compliance, this series addresses how to strategically leverage the No Surprises Act and Transparency in Coverage to create a competitive advantage for both the employer and employees. In this session we will include a focus on leveraging Acquisition Cost Based Pharmacy Pricing as well as Behavioral Design and Messaging as an example of a strategic action organizations can take to optimize this compliance opportunity.

Pharmacy Transparency Key Takeaways

During this session, participants will learn:

• Transparency is a misnomer – New rules don’t provide transparency
• Pharmacy is likely to continue to be rather “opaque”
• The conundrum – mere compliance will likely increase costs, administration, and litigation risk
• How to use Acquisition Cost Based Pharmacy Pricing as well as Behavioral Design and Messaging as examples of strategic actions to:
  • Avoid what can be avoided
  • Provide true transparency with pharmacy benefits
  • Empower consumers to make better, more clinically appropriate decisions
  • Communicate all negatives as the result of compliance
  • Inform/educate consumers (before they become patients)